Rare Cancers Australia CEO Christine Cockburn added, “These results offer real hope to people living with soft tissue sarcoma and other rare cancers, who too often face limited treatment options and poor outcomes." …
QBiotics' candidate produces strong efficacy result in soft tissue sarcoma trial
June 25, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Brandon BioCatalyst welcomes the inclusion of its CUREator in new program
July 16, 2025 - - Australian Biotech -
Cancer Australia launches research program targeting early-onset cancers
July 16, 2025 - - Latest News -
Imugene completes significant placement and launches share purchase plan
July 16, 2025 - - Australian Biotech -
Lumos Diagnostics signs FebriDx US Distribution Agreement with PHASE Scientific
July 16, 2025 - - Australian Biotech -
Noxopharm confirms first patient dosed in SOF-SKN HERACLES trial
July 16, 2025 - - Australian Biotech -
Final days to help build Australia’s longest running life sciences benchmark survey
July 15, 2025 - - Latest News -
New Australian collaboration to build gene and cell therapy production
July 15, 2025 - - Latest News